Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Debt / NOTE 3.000% 6/0
-
Market price (% of par)
-
125.59%
-
Total 13F principal
-
$129,764,000
-
Principal change
-
+$1,150,000
-
Total reported market value
-
$162,630,000
-
Number of holders
-
16
-
Value change
-
+$6,548,656
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 as of Q1 2015
As of 31 Mar 2015,
ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 was held by
16 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$129,764,000
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT CO, EcoR1 Capital, LLC, WOLVERINE ASSET MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, QVT Financial LP, Citadel Advisors LLC, CSS LLC/IL, Polar Securities Inc., Redmile Group, LLC, and Mohican Financial Management, LLC.
This page lists
16
institutional bondholders reporting positions
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.